Abstract
Radiation has been a well-established modality in cancer treatment for several decades. Significant improvements have been achieved in radiotherapy over the years due to technological advances and development of facilities for delivery of charged particles such as protons. Nonetheless, the potential for tumor control with radiotherapy must always be carefully balanced with the risk for normal tissue damage. In addition, tumor cells outside the immediate field of radiation exposure or that have metastasized to distant sites are not destroyed. Gene therapy offers many exciting possibilities by which the overall efficacy of radiotherapy may be improved, while minimizing unwanted side effects. This review highlights several of the most promising gene transfer approaches that are currently being evaluated in combination with radiation in the treatment of cancer. Results from studies utilizing genes encoding molecules that function in apoptosis, radiosensitization, immune up-regulation, angiogenesis, DNA repair, normal tissue protection from radiation damage, and tumor targeting are discussed. The evidence indicates that many of these innovative gene-based strategies have great potential to augment radiotherapy, as well as other established forms of cancer treatment, in the near future.
Keywords: ionizing radiation, protons, radiosensitization, radiation-inducible promoters, targeted gene therapy, suicide genes, immunogenes
Current Gene Therapy
Title: Combining Gene Therapy and Radiation Against Cancer
Volume: 4 Issue: 3
Author(s): Daila S. Gridley and James M. Slater
Affiliation:
Keywords: ionizing radiation, protons, radiosensitization, radiation-inducible promoters, targeted gene therapy, suicide genes, immunogenes
Abstract: Radiation has been a well-established modality in cancer treatment for several decades. Significant improvements have been achieved in radiotherapy over the years due to technological advances and development of facilities for delivery of charged particles such as protons. Nonetheless, the potential for tumor control with radiotherapy must always be carefully balanced with the risk for normal tissue damage. In addition, tumor cells outside the immediate field of radiation exposure or that have metastasized to distant sites are not destroyed. Gene therapy offers many exciting possibilities by which the overall efficacy of radiotherapy may be improved, while minimizing unwanted side effects. This review highlights several of the most promising gene transfer approaches that are currently being evaluated in combination with radiation in the treatment of cancer. Results from studies utilizing genes encoding molecules that function in apoptosis, radiosensitization, immune up-regulation, angiogenesis, DNA repair, normal tissue protection from radiation damage, and tumor targeting are discussed. The evidence indicates that many of these innovative gene-based strategies have great potential to augment radiotherapy, as well as other established forms of cancer treatment, in the near future.
Export Options
About this article
Cite this article as:
Gridley S. Daila and Slater M. James, Combining Gene Therapy and Radiation Against Cancer, Current Gene Therapy 2004; 4 (3) . https://dx.doi.org/10.2174/1566523043346318
DOI https://dx.doi.org/10.2174/1566523043346318 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy
Current Cancer Drug Targets PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Glycolipid Antigen – Mediated Invariant NKT Cell Activation in Microbial Immunity
Current Immunology Reviews (Discontinued) Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts
Mini-Reviews in Medicinal Chemistry Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach
Current Gene Therapy Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Exogenous Expression of WNT7A in Leukemia-Derived Cell Lines Induces Resistance to Chemotherapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Chelating Agents and their Use in Radiopharmaceutical Sciences
Mini-Reviews in Medicinal Chemistry Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Current Diabetes Reviews The Urokinase Receptor and its Structural Homologue C4.4A in Human Cancer: Expression, Prognosis and Pharmacological Inhibition
Current Medicinal Chemistry The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review
Current Medicinal Chemistry Astrocytes as a 5-HT2B-Mediated SERT-Independent SSRI Target, Slowly Altering Depression-Associated Genes and Function
Current Signal Transduction Therapy Curcumin Targets Circulating Cancer Stem Cells by Inhibiting Self-Renewal Efficacy in Non-Small Cell Lung Carcinoma
Anti-Cancer Agents in Medicinal Chemistry New Emerging One Dimensional Nanostructure Materials for Gas Sensing Application: A Mini Review
Current Analytical Chemistry Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Nano-Tetrandrine Efficiently Inhibits the Proliferation and Induces the Apoptosis of Hep2 Cells through a Mitochondrial Signaling Pathway
Current Signal Transduction Therapy Medical Treatment of Overactive Bladder: An Overview
Current Clinical Pharmacology